Table of Contents

• Structure-Based Classification System for EGFR Mutations May Help Clinicians Personalize Treatments for More Patients
• Beloved Oncologist Dr. Philip D. Bonomi to Retire June 30, 2022
• Reflections on Nearly 50 Years in Oncology
• More Robust Tools Needed to Predict who will Respond to Immune Checkpoint Inhibitors
• In Brief for June 22, 2022
• Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates
• Comparable Efficacy, Disruptive Price for an Alternative EGFR TKI?
• Lung Cancer Risk Prediction Model Demonstrates Readiness for Clinical Application
• Using Comparative Effectiveness Data Based on Non-Randomized Study Designs to Support Regulatory, Reimbursement Decision-Making
• In Measuring Outcomes, a Longer-Term View May be Needed
• In Brief for June 8, 2022

IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.